Observed Signal · Oct 23, 2026 · Investment Analysis · Source: CNBC Investing · Impact: 3/5 · Sentiment: Positive
Contrarian Investor Paul Meeks Recommends Buying Cerebras at 72% Discount
Contrarian tech investor Paul Meeks, Managing Director and Head of Technology Research at Freedom Capital Markets, reversed his stance on AI chipmaker Cerebras Systems. He had warned against buying the stock at its IPO and peak, but now sees a compelling opportunity after shares plunged roughly 72% from their high. Meeks highlights Cerebras's innovative Wafer-Scale Engine, which offers competitive advantages in AI inference. The company has about $25 billion in remaining performance obligations, including $20 billion tied to OpenAI, far exceeding its current quarterly core revenue of $210 million. Concerns about OpenAI using Nvidia chips are seen as overblown. Meeks sets a price target of $209, implying 91% upside, and expects revenue to triple to $2.8 billion by 2027.
The article provides a contrarian investor's bullish analysis of Cerebras, a major AI chip company, which could influence market sentiment and investment decisions in the AI infrastructure sector, relevant to AdTech's underlying technology ecosystem.
Track Cerebras Systems Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Cerebras Systems stock has fallen roughly 72% from its peak.
- Meeks sets a price target of $209, implying 91% upside from current levels.
- Cerebras has $25 billion in remaining performance obligations, including $20 billion from OpenAI.
- Cerebras generated $210 million in core revenue last quarter.
- Meeks partners with AWS to develop inference disaggregation using Trainium and Cerebras chips.
Connected Companies & Entities
4 Entities mapped“Sunnyvale, California-based AI chipmaker now trading at around $107”
“OpenAI accounts for approximately $20 billion of Cerebras' contracted business”
“Partnership with AWS to develop inference disaggregation using Trainium chips”
“Speculation that OpenAI used Nvidia chips rather than Cerebras hardware”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Cerebras IPO Soars, Raises Revenue and Risk Concerns
Cerebras, an AI chipmaker, completed a large IPO in May 2026 that opened well above its offering price but has drawn scrutiny over valuation, customer concentration and financial sustainability. Shares were priced at $185 and opened at $350 (an 89% pop) before slipping ~10% the following day. The company has a market capitalization above $60 billion while reporting roughly $510 million in revenue, producing an unusually high price-to-sales multiple. A large share of Cerebras’ revenue is tied to UAE state-backed customers — the newsletter cites 62% of revenue from Mohamed bin Zayed University of AI and an effective 86% exposure to a single sovereign‑backed buyer — and highlights an OpenAI deployment agreement that could scale to ~$7 billion annual revenue at full capacity but includes exclusivity clauses. The article contrasts Cerebras’ wafer-scale chips with incumbent Nvidia, which holds ~85% market share and whose AI chip business is far larger.
Cerebras stock hits post-IPO low amid Nvidia pressure
Cerebras Systems' stock experienced a volatile week, dropping nearly 20% to $166.43 after reports that Nvidia would power OpenAI's 'Ultrafast' mode for GPT-6.1 Sol, taking a key inference workload from Cerebras. However, the stock recovered about 9% on Monday after OpenAI CEO Sam Altman called Cerebras a 'close partner.' Despite this, the stock remains down over 50% from its IPO price, and insider selling by CEO Andrew Feldman and CTO Sean Lie (over $240 million) has exacerbated declines. Cerebras' market cap fell from $95 billion at May IPO to about $43 billion. Citi analysts maintained their revenue outlook, noting that frontier labs often initially deploy models on internal chips, and emphasized the need for stabilizing gross margins.
Cerebras Eyes $26.6B Blockbuster IPO
Cerebras Systems filed to sell 28 million shares at $115–$125 each, a range that would raise about $3.5 billion and imply a roughly $26.6 billion market capitalization at the high end. The AI chipmaker, maker of the Wafer-Scale Engine 3 which it says is faster and more power-efficient for inference than GPU alternatives, counts major investors and customers across the venture and sovereign-capital spectrum. OpenAI has a close commercial relationship with Cerebras—including a $1 billion loan secured by warrants that could let OpenAI buy over 33 million shares—and is one of its largest customers. The SEC filing names top shareholders (Alpha Wave, Benchmark, Eclipse, Fidelity, Foundation Capital) and numerous other institutional and angel backers. Banks are reporting strong demand, with coverage noting roughly $10 billion of orders against the $3.5 billion offering size.
Receive all future signals for Cerebras Systems & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.